Veracyte, Inc.
VCYT
$32.13
$1.203.88%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 66.35M | 30.32M | 26.34M | 33.05M | 24.14M |
| Total Depreciation and Amortization | 21.42M | 22.37M | 22.98M | 23.23M | 23.46M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 50.84M | 67.19M | 62.23M | 46.66M | 48.46M |
| Change in Net Operating Assets | -2.30M | -11.63M | -18.10M | -13.52M | -20.97M |
| Cash from Operations | 136.31M | 108.25M | 93.45M | 89.42M | 75.10M |
| Capital Expenditure | -9.68M | -10.04M | -9.49M | -10.97M | -11.29M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | 0.00 | 0.00 | 0.00 | 5.01M |
| Divestitures | -2.85M | -- | -- | -- | -- |
| Other Investing Activities | 3.31M | -47.88M | -98.94M | -100.00M | -50.00M |
| Cash from Investing | -9.21M | -57.92M | -108.43M | -110.97M | -56.28M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 14.08M | 13.84M | 20.51M | 19.99M | 19.99M |
| Repurchase of Common Stock | -18.30M | -17.92M | -17.29M | -16.21M | -10.59M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -4.50M | -4.50M | -4.50M | -4.50M |
| Cash from Financing | -4.22M | -8.58M | -1.27M | -716.00K | 4.90M |
| Foreign Exchange rate Adjustments | 719.00K | 306.00K | 392.00K | -242.00K | -424.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 123.60M | 42.05M | -15.85M | -22.51M | 23.30M |